These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

652 related items for PubMed ID: 29162393

  • 1. PCR-based discrimination of emerging Streptococcus pneumoniae serotypes 22F and 33F.
    Gillis HD, Demczuk WHB, Griffith A, Martin I, Warhuus M, Lang ALS, ElSherif M, McNeil SA, LeBlanc JJ.
    J Microbiol Methods; 2018 Jan; 144():99-106. PubMed ID: 29162393
    [Abstract] [Full Text] [Related]

  • 2. Invasive Streptococcus pneumoniae in Canada, 2011-2014: Characterization of new candidate 15-valent pneumococcal conjugate vaccine serotypes 22F and 33F.
    Golden AR, Adam HJ, Zhanel GG, Canadian Antimicrobial Resistance Alliance (CARA).
    Vaccine; 2016 May 17; 34(23):2527-30. PubMed ID: 27085174
    [Abstract] [Full Text] [Related]

  • 3. 23-valent polysaccharide vaccine (PPSV23)-targeted serotype-specific identification of Streptococcus pneumoniae using the loop-mediated isothermal amplification (LAMP) method.
    Lee J, Yoon Y, Kim EJ, Lee D, Baek Y, Takano C, Chang B, Iijima T, Kilgore PE, Hayakawa S, Hoshino T, Kim DW, Seki M.
    PLoS One; 2021 May 17; 16(2):e0246699. PubMed ID: 33591996
    [Abstract] [Full Text] [Related]

  • 4. Whole genome characterization of Streptococcus pneumoniae from respiratory and blood cultures collected from Canadian hospitals before and after PCV-13 implementation in Canada: Focus on serotypes 22F and 33F from CANWARD 2007-2018.
    Golden AR, Adam HJ, Baxter M, Martin I, Demczuk W, Mulvey MR, Karlowsky JA, Zhanel GG, Canadian Antimicrobial Resistance Alliance (CARA).
    Vaccine; 2021 Sep 15; 39(39):5474-5483. PubMed ID: 34454785
    [Abstract] [Full Text] [Related]

  • 5. Discovery of a Streptococcus pneumoniae serotype 33F capsular polysaccharide locus that lacks wcjE and contains a wcyO pseudogene.
    Manna S, Dunne EM, Ortika BD, Pell CL, Kama M, Russell FM, Mungun T, Mulholland EK, Hinds J, Satzke C.
    PLoS One; 2018 Sep 15; 13(11):e0206622. PubMed ID: 30395578
    [Abstract] [Full Text] [Related]

  • 6. Invasive pneumococcal disease due to 22F and 33F in England: A tail of two serotypes.
    Amin-Chowdhury Z, Groves N, Sheppard CL, Litt D, Fry NK, Andrews N, Ladhani SN.
    Vaccine; 2021 Apr 01; 39(14):1997-2004. PubMed ID: 33715901
    [Abstract] [Full Text] [Related]

  • 7. Using cpsA-cpsB sequence polymorphisms and serotype-/group-specific PCR to predict 51 Streptococcus pneumoniae capsular serotypes.
    Kong F, Gilbert GL.
    J Med Microbiol; 2003 Dec 01; 52(Pt 12):1047-1058. PubMed ID: 14614062
    [Abstract] [Full Text] [Related]

  • 8. Invasive pneumococcal disease caused by serotypes 22F and 33F in Canada: the SAVE study 2011-2018.
    Golden AR, Fear T, Baxter M, Adam HJ, Martin I, Demczuk W, Karlowsky JA, Zhanel GG, Canadian Antimicrobial Resistance Alliance (CARA).
    Diagn Microbiol Infect Dis; 2021 Oct 01; 101(2):115447. PubMed ID: 34192638
    [Abstract] [Full Text] [Related]

  • 9. High-throughput nanofluidic real-time PCR to discriminate Pneumococcal Conjugate Vaccine (PCV)-associated serogroups 6, 18, and 22 to serotypes using modified oligonucleotides.
    Downs SL, Madhi SA, Van der Merwe L, Nunes MC, Olwagen CP.
    Sci Rep; 2021 Dec 09; 11(1):23728. PubMed ID: 34887480
    [Abstract] [Full Text] [Related]

  • 10. Assessing the impact of pneumococcal conjugate vaccines on invasive pneumococcal disease using polymerase chain reaction-based surveillance: an experience from South Africa.
    Tempia S, Wolter N, Cohen C, Walaza S, von Mollendorf C, Cohen AL, Moyes J, de Gouveia L, Nzenze S, Treurnicht F, Venter M, Groome MJ, Madhi SA, von Gottberg A.
    BMC Infect Dis; 2015 Oct 26; 15():450. PubMed ID: 26496761
    [Abstract] [Full Text] [Related]

  • 11. Population structure and drug resistance patterns of emerging non-PCV-13 Streptococcus pneumoniae serotypes 22F, 15A, and 8 isolated from adults in Ontario, Canada.
    Duvvuri VR, Deng X, Teatero S, Memari N, Athey T, Fittipaldi N, Gubbay JB.
    Infect Genet Evol; 2016 Aug 26; 42():1-8. PubMed ID: 27071529
    [Abstract] [Full Text] [Related]

  • 12. Immunogenicity and protective efficacy of monovalent PCVs containing 22F and 33F polysaccharides in mouse models of colonization and co-infection.
    Khan MN, Pryharski K, Pichichero ME.
    Vaccine; 2018 Sep 11; 36(38):5701-5708. PubMed ID: 30107993
    [Abstract] [Full Text] [Related]

  • 13. Practical Prediction of Ten Common Streptococcus pneumoniae Serotypes/Serogroups in One PCR Reaction by Multiplex Ligation-Dependent Probe Amplification and Melting Curve (MLPA-MC) Assay in Shenzhen, China.
    Wu L, Yin X, Zheng L, Zou J, Jin P, Hu Y, Kudinha T, Kong F, Chen X, Wang Q.
    PLoS One; 2015 Sep 11; 10(7):e0130664. PubMed ID: 26151828
    [Abstract] [Full Text] [Related]

  • 14. Genetic diversity of the pneumococcal capsule: implications for molecular-based serotyping.
    McEllistrem MC.
    Future Microbiol; 2009 Sep 11; 4(7):857-65. PubMed ID: 19722839
    [Abstract] [Full Text] [Related]

  • 15. Assessment of multidrug resistance, clonality and virulence in non-PCV-13 Streptococcus pneumoniae serotypes in Canada, 2011-13.
    Golden AR, Adam HJ, Gilmour MW, Baxter MR, Martin I, Nichol KA, Demczuk WH, Hoban DJ, Zhanel GG.
    J Antimicrob Chemother; 2015 Jul 11; 70(7):1960-4. PubMed ID: 25761605
    [Abstract] [Full Text] [Related]

  • 16. Identification and capsular serotype sequetyping of Streptococcus pneumoniae strains.
    Gonzales-Siles L, Salvà-Serra F, Degerman A, Nordén R, Lindh M, Skovbjerg S, Moore ERB.
    J Med Microbiol; 2019 Aug 11; 68(8):1173-1188. PubMed ID: 31268417
    [Abstract] [Full Text] [Related]

  • 17. Molecular characterization of predominant Streptococcus pneumoniae serotypes causing invasive infections in Canada: the SAVE study, 2011-15.
    Golden AR, Adam HJ, Karlowsky JA, Baxter M, Nichol KA, Martin I, Demczuk W, Van Caeseele P, Gubbay JB, Lefebvre B, Levett PN, Zahariadis G, Haldane D, Gad R, German G, Gilmour MW, Mulvey MR, Hoban DJ, Zhanel GG, Canadian Antimicrobial Resistance Alliance (CARA).
    J Antimicrob Chemother; 2018 Jul 01; 73(suppl_7):vii20-vii31. PubMed ID: 29982573
    [Abstract] [Full Text] [Related]

  • 18. Application of capsular sequence typing (CST) to serotype non-viable Streptococcus pneumoniae isolates from an old collection.
    Errico G, Lucarelli C, D'Ambrosio F, Del Grosso M, Ingrosso L, Pantosti A, Camilli R.
    Eur J Clin Microbiol Infect Dis; 2016 Dec 01; 35(12):2025-2031. PubMed ID: 27580910
    [Abstract] [Full Text] [Related]

  • 19. Multiplex PCR for identification of seven Streptococcus pneumoniae serotypes targeted by a 7-valent conjugate vaccine.
    O'halloran DM, Cafferkey MT.
    J Clin Microbiol; 2005 Jul 01; 43(7):3487-90. PubMed ID: 16000486
    [Abstract] [Full Text] [Related]

  • 20. Five winters of pneumococcal serotype replacement in UK carriage following PCV introduction.
    Gladstone RA, Jefferies JM, Tocheva AS, Beard KR, Garley D, Chong WW, Bentley SD, Faust SN, Clarke SC.
    Vaccine; 2015 Apr 21; 33(17):2015-21. PubMed ID: 25776920
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.